Correction: Krayem et al. The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma. Cancers 2019, 11, 1093

Cancers (Basel). 2023 Dec 15;15(24):5860. doi: 10.3390/cancers15245860.

Mohammad Krayem^{1

2}, Malak Sabbah¹, Ahmad Najem¹, An Wouters³, Filip Lardon³, Stephane Simon², François Sales¹, Fabrice Journe^{1

4}, Ahmad Awada^{1

5}, Ghanem E Ghanem¹, Dirk Van Gestel²

¹ Laboratory of Oncology and Experimental Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Rue Héger-Bordet 1, 1000 Brussels, Belgium.
² Department of Radiation Oncology, Institut Jules Bordet, Université libre de Bruxelles, 1000 Brussels, Belgium.
³ Center for Oncological Research (CORE), University of Antwerp, 2610 Wilrijk, Belgium.
⁴ Department of Human Anatomy and Experimental Oncology, Université de Mons (UMons), Research Institute for Health Sciences and Technology, 7000 Mons, Belgium.
⁵ Department of Internal Medicine, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium.

Abstract

In the original article [...].